Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Hirsch

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Journal of Virology|February 1, 1984
Development of antibody to measles virus polypeptides during complicated and uncomplicated measles virus infectionsM Graves, D E Griffin, R T Johnson, et al.
Australian Clinical Review|January 1, 1990
Experience of a concurrent screening quality assurance programme in an emergency departmentK Manning, M M Lawrence-Brown, R L Hirsch, et al.
The New England Journal of Medicine|January 19, 1984
Measles encephalomyelitis--clinical and immunologic studiesR T Johnson, D E Griffin, R L Hirsch, et al.
Lancet (London, England)|August 2, 1980
Cerebrospinal-fluid lymphocyte populations and immune complexes in active multiple sclerosisP K Coyle, B R Brooks, R L Hirsch, et al.
The Journal of Allergy and Clinical Immunology|August 1, 1985
Changes in plasma IgE levels during complicated and uncomplicated measles virus infectionsD E Griffin, S J Cooper, R L Hirsch, et al.
Transactions of the American Neurological Association|January 1, 1981
Clinical and immunological studies of measles encephalitisR T Johnson, R L Hirsch, D E Griffin, et al.
Clinical Immunology and Immunopathology|April 1, 1984
Cellular immune responses during complicated and uncomplicated measles virus infections of manR L Hirsch, D E Griffin, R T Johnson, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|March 1, 1995
Safety and efficacy of thymopentin in zidovudine (AZT)-treated asymptomatic HIV-infected subjects with 200-500 CD4 cells/mm3: a double-blind placebo-controlled trialG Goldstein, M A Conant, G Beall, et al.
The Journal of Allergy and Clinical Immunology|May 1, 1990
Thymopentin therapy reduces the clinical severity of atopic dermatitisD Y Leung, R L Hirsch, L Schneider, et al.
AIDS (London, England)|November 1, 1992
Maintenance of CD4+ cells by thymopentin in asymptomatic HIV-infected subjects: results of a double-blind, placebo-controlled studyM A Conant, L H Calabrese, S E Thompson, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Journal of Virology|February 1, 1984
Development of antibody to measles virus polypeptides during complicated and uncomplicated measles virus infectionsM Graves, D E Griffin, R T Johnson, et al.
Australian Clinical Review|January 1, 1990
Experience of a concurrent screening quality assurance programme in an emergency departmentK Manning, M M Lawrence-Brown, R L Hirsch, et al.
The New England Journal of Medicine|January 19, 1984
Measles encephalomyelitis--clinical and immunologic studiesR T Johnson, D E Griffin, R L Hirsch, et al.
Lancet (London, England)|August 2, 1980
Cerebrospinal-fluid lymphocyte populations and immune complexes in active multiple sclerosisP K Coyle, B R Brooks, R L Hirsch, et al.
The Journal of Allergy and Clinical Immunology|August 1, 1985
Changes in plasma IgE levels during complicated and uncomplicated measles virus infectionsD E Griffin, S J Cooper, R L Hirsch, et al.
Transactions of the American Neurological Association|January 1, 1981
Clinical and immunological studies of measles encephalitisR T Johnson, R L Hirsch, D E Griffin, et al.
Clinical Immunology and Immunopathology|April 1, 1984
Cellular immune responses during complicated and uncomplicated measles virus infections of manR L Hirsch, D E Griffin, R T Johnson, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|March 1, 1995
Safety and efficacy of thymopentin in zidovudine (AZT)-treated asymptomatic HIV-infected subjects with 200-500 CD4 cells/mm3: a double-blind placebo-controlled trialG Goldstein, M A Conant, G Beall, et al.
The Journal of Allergy and Clinical Immunology|May 1, 1990
Thymopentin therapy reduces the clinical severity of atopic dermatitisD Y Leung, R L Hirsch, L Schneider, et al.
AIDS (London, England)|November 1, 1992
Maintenance of CD4+ cells by thymopentin in asymptomatic HIV-infected subjects: results of a double-blind, placebo-controlled studyM A Conant, L H Calabrese, S E Thompson, et al.
Pageof 9